Ñó÷àñí³ ï³äõîäè äî ë³êóâàííÿ õâîðèõ íà õðîí³÷íèé ãåïàòèò Ñ ç íàÿâí³ñòþ ïîçà ïå÷³íêîâèõ ïðîÿâ³â ÞÞ Ðÿáîêîíü, ÎÏ Ìàøêî, À Àáðàìîâ, ÄÏ ²ïàòîâà, ÄÏ Èïàòîâà ÇÄÌÓ, 2013 | 2 | 2013 |
Åôåêòèâí³ñòü ð³çíèõ ñõåì ïðîòèâ³ðóñíîãî ë³êóâàííÿ õâîðèõ íà õðîí³÷íèé ãåïàòèò Ñ, ³íô³êîâàíèõ 3-ì ãåíîòèïîì â³ðóñó EV Riabokon, KV Kalashnik, EV Tsareva, DP Ipatova, YY Riabokon ACTUAL INFECTOLOGY 6 (1), 24-27, 2018 | 1 | 2018 |
Åôåêòèâí³ñòü ïîäâ³éíî¿ ïðîòèâ³ðóñíî¿ òåðàﳿ òà äèíàì³êà ïîêàçíèê³â ÿêîñò³ æèòòÿ ó õâîðèõ íà õðîí³÷íèé ãåïàòèò Ñ çàëåæíî â³ä â³äïîâ³ä³ íà ë³êóâàííÿ (Çà ðåçóëüòàòàìè âèêîíàííÿ … ΠÐÿáîêîíü, Ê Êàëàøíèê, ΠËÿäñüêà, ÄÏ ²ïàòîâà, ÞÞ Ðÿáîêîíü Ãåïàòîëîã³ÿ, 22-31, 2017 | 1 | 2017 |
Êîãí³òèâí³ òåõíîëî㳿 ó íàâ÷àíí³ ñòóäåíò³â ÞÞ Ðÿáîêîíü, Òª Îí³ùåíêî, ÎÎ Ôóðèê, ÄÏ ²ïàòîâà Çàïîð³çüêèé äåðæàâíèé ìåäè÷íèé óí³âåðñèòåò, 2014 | 1 | 2014 |
Õðîí³÷íèé ãåïàòèò Ñ ó õâîðèõ ç àáäîì³íàëüíèì îæèð³ííÿì: êë³í³êî-ïàòîãåíåòè÷í³ îñîáëèâîñò³ òà ñó÷àñí³ ìîæëèâîñò³ îïòèì³çàö³¿ ë³êóâàííÿ ³ç çàñòîñóâàííÿì åñåíö³éíèõ ôîñôîë³ï³ä³â ΠÐÿáîêîíü, ÄÏ ²ïàòîâà, ËÎ Óøåí³íà Ñó÷àñíà ãàñòðîåíòåðîëîã³ÿ, 111-118, 2013 | 1 | 2013 |
Äèíàì³êà ïîêàçíèê³â ôåðîê³íåòèêè ó õâîðèõ íà õðîí³÷íèé ãåïàòèò Ñ ï³ä âïëèâîì ïðîòèâ³ðóñíî¿ òåðàﳿ Ë Ìîðîç, ÂÌ Äóäíèê, ÄÏ ²ïàòîâà | 1 | 2009 |
Îñîáëèâîñò³ òà çàñîáè ôîðìóâàííÿ ïðîôåñ³éíî¿ êóëüòóðè ìàéáóòí³õ ë³êàð³â ÄÏ ²ïàòîâà, ÞÞ Ðÿáîêîíü, ÄÀ Çàäèðàêà, ÀÁ Õåëåìåíäèê, ΠÀí³ê³íà Ê.: Ãíîçèñ, 2018 | | 2018 |
²ííîâàö³éí³ òåõíîëî㳿 ó âèù³é îñâ³ò³ ÄÏ ²ïàòîâà ÂÈÙÀ ÎѲÒÀ ÓÊÐÀ¯ÍÈ Ó ÊÎÍÒÅÊÑÒ² ²ÍÒÅÃÐÀÖ²¯ ÄÎ ªÂÐÎÏÅÉÑÜÊÎÃÎ ÎѲÒÍÜÎÃÎ …, 2017 | | 2017 |
EFFICIENCY AND DYNAMIC ANTIVIRALTHERAPY AND INDICATORS OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEPATITIS C DEPENDING ON AVAILABILITY MIXED CRYOGLOBULIN OV Riabokon, OV Liadska, DP Ipatova, YY Riabokon ÒÍÌÓ, 2017 | | 2017 |
The involvement of medical students to research a step in training ÄÏ ²ÏÀÒÎÂÀ ÂÈÙÀ ÎѲÒÀ ÓÊÐÀ¯ÍÈ Ó ÊÎÍÒÅÊÑÒ² ²ÍÒÅÃÐÀÖ²¯ ÄÎ ªÂÐÎÏÅÉÑÜÊÎÃÎ ÎѲÒÍÜÎÃÎ …, 2016 | | 2016 |
ÂÏÐÎÂÀÄÆÅÍÍß ÎѲÒÍ²Õ ²ÍÍÎÂÀÖ²É Ó ÑÈÑÒÅÌÓ Ï²ÄÂÈÙÅÍÍß ÊÂÀ˲ԲÊÀÖ²¯ ÏÅÄÀÃÎò×ÍÈÕ ÏÐÀÖ²ÂÍÈʲ ßÊ ÍÀÓÊÎÂÀ ÏÐÎÁËÅÌÀ ÄÏ ²ÏÀÒÎÂÀ ̲ÆÍÀÐÎÄͲ ×ÅËÏÀͲÂÑÜʲ ÏÑÈÕÎËÎÃÎ-ÏÅÄÀÃÎò×Ͳ ×ÈÒÀÍÍß 19, 265-272, 2016 | | 2016 |
Åôåêòèâí³ñòü ïðîòèâ³ðóñíî¿ òåðàﳿ òà äèíàì³êà ïîêàçíèê³â ÿêîñò³ æèòòÿ õâîðèõ íà õðîí³÷íèé ãåïàòèò Ñ çàëåæíî â³ä íàÿâíîñò³ çì³øàíî¿ êð³îãëîáóë³íå쳿 ΠÐÿáîêîíü, ΠËÿäñüêà, ÄÏ ²ïàòîâà, ÞÞ Ðÿáîêîíü ²íôåêö³éí³ õâîðîáè, 30-35, 2016 | | 2016 |
Ô²ÁÐÎÇÓÞ×ÈÉ ÀËÜÂÅÎË²Ò ßÊ ÏÎÇÀÏÅײÍÊÎÂÈÉ ÏÐÎß  ÓÌÎÂÀÕ ÑÈÑÒÅÌÍÎÑÒ² ÓÐÀÆÅÍÜ ÏÐÈ ÕÐÎͲ×Í²É HCV-²ÍÔÅÊÖ²¯ ÌÀ Àíäðåé÷èí, ÄÏ ²ïàòîâà, ÞÞ Ðÿáîêîíü ÒÃÌÓ, 2015 | | 2015 |
ÏÎÊÀÇÍÈÊÈ ÔÓÍÊÖ²¯ ÅÍÄÎÒÅË²Þ Ó ÕÂÎÐÈÕ ÍÀ ÕÐÎͲ×ÍÈÉ ÃÅÏÀÒÈÒ Ñ Ç ÊвÎÃËÎÁÓ˲ÍÅ̲ªÞ ÍÀ Ò˲ ÏÐÎÒȲÐÓÑÍÎÃΠ˲ÊÓÂÀÍÍß ÌÀ Àíäðåé÷èí, ÄÏ ²ïàòîâà, ÞÞ Ðÿáîêîíü, À Àáðàìîâ ÒÃÌÓ, 2015 | | 2015 |
Ïîêàçíèêè ôóíêö³¿ åíäîòåë³þ ó õâîðèõ íà õðîí³÷íèé ãåïàòèò Ñ ç êð³îãëîáóë³íå쳺þ íà òë³ ïðîòèâ³ðóñíîãî ë³êóâàííÿ ÞÞ Ðÿáîêîíü, ÌÀ Àíäðåé÷èí, À Àáðàìîâ, ÄÏ ²ïàòîâà | | 2014 |
Ô³áðîçóþ÷èé àëüâåîë³ò ÿê ïîçàïå÷³íêîâèé ïðîÿâ â óìîâàõ ñèñòåìíîñò³ óðàæåíü ïðè õðîí³÷í³é HCV-³íôåêö³¿ ÞÞ Ðÿáîêîíü, ÄÏ ²ïàòîâà ²íôåêö³éí³ õâîðîáè, 101-105, 2014 | | 2014 |
Ãåìîñèäåðîç ïå÷³íêè ó õâîðèõ íà õðîí³÷íèé ãåïàòèò Ñ Ë Ìîðîç, ÎÔ Òóðñüêèé, ÎÀ Îë³ïåð, ÄÏ ²ïàòîâà ³ñíèê ìîðôîëî㳿, 1, 2009 | | 2009 |
ÎÑÎÁËÈÂÎÑÒ² ÔÅÐÎʲÍÅÒÈÊÈ Ó ÕÂÎÐÈÕ ÍÀ ÕÐÎͲ×ÍÈÉ ÃÅÏÀÒÈÒ Ñ Â ÄÈÍÀֲ̲ ÏÐÎÒȲÐÓÑÍί ÒÅÐÀϲ¯ 14.01. 13–³íôåêö³éí³ õâîðîáè ÄÏ ²ÏÀÒÎÂÀ | | |